B
Boomerang Medical
A bioelectronic medicine company targeting the treatment of autoimmune diseases
About Boomerang Medical
Boomerang Medical is a clinical-stage medical device company that is developing a bioelectronic therapy for the treatment of autoimmune diseases. The company's initial focus is on inflammatory bowel disease (IBD), a chronic inflammatory condition of the gastrointestinal tract that affects millions of people worldwide.
Boomerang's therapy is based on the principle of neuromodulation, which involves the use of electrical stimulation to modulate the activity of the nervous system. The company has developed a proprietary neurostimulation device that is implanted in the wrist and delivers electrical pulses to the median nerve. This stimulation is intended to activate the body's natural anti-inflammatory reflex, which helps to reduce inflammation and improve symptoms in patients with IBD.
The company is currently conducting a pilot study to evaluate the safety and efficacy of its therapy in patients with IBD. The study is being conducted at multiple sites in the United States and is expected to enroll up to 60 patients. Boomerang has received FDA approval for its Investigational Device Exemption (IDE) application, which allows the company to conduct its pilot study.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2025 | $20M | $80M | Hatteras Venture Partners · Arboretum Ventures | ↗ |
| SERIES A✓Equity / VC | Nov 2022 | $15M | $60M | Hatteras Venture Partners · Arboretum Ventures | ↗ |
Growth signals
Latest recorded traffic for Boomerang Medical is 890 monthly website visits, up 27.1% over the last three months. Boomerang Medical's team grew 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Boomerang Medical in the Mountain View ecosystem
The Boomerang Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Arboretum Ventures
Series A1 investor entered at this stage
Hatteras Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Boomerang Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Boomerang Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









